[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-detail-195021-en":53,"doc-seo-195021-105":76},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":5,"data":54},{"doc_id":55,"user_id":56,"nickname":57,"user_avatar":58,"doc_module":9,"category_id":50,"category_name":51,"doc_title":59,"doc_description":60,"doc_content":61,"file_id":62,"file_url":63,"file_type":64,"file_size":65,"view_count":66,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":67,"language":68,"language_code":69,"site_id":70,"html_lang":69,"table_of_contents":71,"faqs":72,"seo_title":73,"seo_description":60,"update_tm":74,"read_time":75},195021,13056703019404,"Miles","https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","EP PerMed European Partnership For Personalised Medicine","The European Partnership for Personalised Medicine (EP PerMed) is a collaborative initiative dedicated to advancing the field of personalised medicine across Europe. This partnership brings together researchers, clinicians, industry stakeholders, and policymakers to foster innovation, facilitate knowledge exchange, and accelerate the translation of research findings into clinical practice. EP PerMed aims to address the complex challenges and opportunities associated with personalised medicine, including the development of new diagnostic tools, targeted therapies, and predictive biomarkers. The initiative supports research projects that investigate the underlying mechanisms of diseases, identify patient subgroups, and tailor treatments to individual needs. Furthermore, EP PerMed actively promotes the ethical, legal, and social implications of personalised medicine, ensuring responsible development and implementation of these advanced healthcare approaches. The partnership also focuses on building capacity and expertise within the European research community, facilitating access to cutting-edge technologies, and promoting patient engagement. Through its multifaceted approach, EP PerMed strives to improve patient outcomes, enhance healthcare efficiency, and strengthen Europe's position as a global leader in personalised medicine research and innovation.","","cbCainxyk5g0WFvx","https://ap.wps.com/l/cbCainxyk5g0WFvx","pdf",488640,6,20,"English","en",105,"# EP PerMed\n## European Partnership for Personalised Medicine","[{\"question\":\"What is the primary goal of EP PerMed?\",\"answer\":\"The primary goal of EP PerMed is to advance the field of personalised medicine across Europe by fostering innovation, facilitating knowledge exchange, and accelerating the translation of research into clinical practice.\"},{\"question\":\"Who are the key stakeholders involved in EP PerMed?\",\"answer\":\"EP PerMed brings together researchers, clinicians, industry stakeholders, and policymakers to collaborate on advancing personalised medicine.\"},{\"question\":\"What areas does EP PerMed focus on within personalised medicine?\",\"answer\":\"EP PerMed focuses on the development of new diagnostic tools, targeted therapies, predictive biomarkers, and tailoring treatments to individual patient needs.\"}]","EP PerMed European Partnership For Personalised Medicine | PDF",1788444835,7,{"code":4,"msg":77,"data":78},"ok",{"site_id":70,"language":69,"slug":79,"title":59,"keywords":61,"description":60,"schema_data":80,"social_meta":136,"head_meta":138,"extra_data":140,"updated_unix":141},"ep-permed-european-partnership-for-personalised-medicine",{"@graph":81,"@context":135},[82,98,118],{"@type":83,"itemListElement":84},"BreadcrumbList",[85,89,92,95],{"item":86,"name":87,"@type":88,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":90,"name":10,"@type":88,"position":91},"https://docshare.wps.com/template/",2,{"item":93,"name":51,"@type":88,"position":94},"https://docshare.wps.com/template/general/",3,{"item":96,"name":59,"@type":88,"position":97},"https://docshare.wps.com/template/ep-permed-european-partnership-for-personalised-medicine/195021/",4,{"url":96,"name":59,"@type":99,"image":100,"author":105,"headline":59,"publisher":107,"fileFormat":110,"inLanguage":69,"description":60,"dateModified":111,"datePublished":112,"encodingFormat":110,"isAccessibleForFree":113,"interactionStatistic":114},"DigitalDocument",{"url":101,"@type":102,"width":103,"height":104},"https://docshare.wps.com/thumbnails/ep-permed-european-partnership-for-personalised-medicine/195021.png","ImageObject",442,249,{"name":57,"@type":106},"Person",{"url":86,"name":108,"@type":109},"DocShare","Organization","application/pdf","2026-09-29","2026-09-03",true,{"@type":115,"interactionType":116,"userInteractionCount":66},"InteractionCounter",{"@type":117},"ViewAction",{"@type":119,"mainEntity":120},"FAQPage",[121,127,131],{"name":122,"@type":123,"acceptedAnswer":124},"What is the primary goal of EP PerMed?","Question",{"text":125,"@type":126},"The primary goal of EP PerMed is to advance the field of personalised medicine across Europe by fostering innovation, facilitating knowledge exchange, and accelerating the translation of research into clinical practice.","Answer",{"name":128,"@type":123,"acceptedAnswer":129},"Who are the key stakeholders involved in EP PerMed?",{"text":130,"@type":126},"EP PerMed brings together researchers, clinicians, industry stakeholders, and policymakers to collaborate on advancing personalised medicine.",{"name":132,"@type":123,"acceptedAnswer":133},"What areas does EP PerMed focus on within personalised medicine?",{"text":134,"@type":126},"EP PerMed focuses on the development of new diagnostic tools, targeted therapies, predictive biomarkers, and tailoring treatments to individual patient needs.","https://schema.org",{"og:url":96,"og:type":137,"og:title":59,"og:site_name":108,"og:description":60},"article",{"robots":139,"canonical":96},"index,follow",{"doc_id":55,"site_id":70},1790000923]